Blanc explicitly tied this earnings trajectory to the group's transformation programme, stating that operating profits and dividends are growing as Aviva executes its strategy. The combination of higher operating profit and stronger Solvency II own funds generation provided the platform for further capital returns and growth investment choices.
Capital return and shareholder distributions
Alongside the 2022 results, Aviva announced a new share buyback of £300m, adding another mechanism for returning surplus capital to shareholders. This sits within a broader capital return framework that has exceeded £5bn since 2021, showing the scale of balance sheet reallocation following portfolio simplification.
The distribution framework was anchored by a defined 2022 dividend timetable, with a record date of 31 March and payment date of 17 May for the final dividend. The Annual General Meeting was scheduled for 4 May, providing the governance milestone at which shareholders could vote on the final dividend and review the capital return strategy.
UK & Ireland Life: value over volume
In UK & Ireland Life, value of new business increased 15% to £767m in 2022 from £668m in 2021, evidencing a shift towards higher-margin business. Over the same period, life sales declined to £33bn from £36bn, indicating that the uplift in value was achieved despite lower aggregate volumes.
Within this, Protection & Health value of new business rose 18% to £221m compared with £188m in 2021, highlighting the contribution of risk business to the improved value mix. The combination of higher VNB and lower overall sales points to pricing, product mix and underwriting discipline as key drivers of the life segment's economics.
Bulk annuities and retirement franchise
Aviva reported bulk purchase annuity sales of £4.4bn in 2022, confirming the scale of its participation in the UK de-risking market during the year. Management stated they are confident in meeting a BPA volume target of £15–£20bn over 2022–24, framing 2022's flow as part of a multi-year growth plan in the segment.
Equity release sales increased 17% in 2022, supported by strong demand, reinforcing the breadth of Aviva's retirement proposition across both annuities and later-life lending. Together, the BPA and equity release flows feed directly into the group's long-term savings and retirement balance sheet, with implications for matching adjustment portfolios and asset origination over the coming years.
Management narrative and transformation progress
Blanc's commentary linked the financial outcomes to the broader transformation story, emphasising "excellent progress" and "strong trading momentum" against a backdrop of market volatility. The combination of higher operating profit, stronger Solvency II own funds generation and substantial capital return since 2021 formed the core of that narrative.
Aviva formally announced the 2022 full-year results on 9 March. The financial calendar aligned the results disclosure, AGM and dividend events into a coherent investor engagement sequence.
This structure underpinned the presentation of 2022 as a year in which the reshaped group began to translate its strategic repositioning into sustained earnings, capital and distribution outcomes.
Looking ahead, the next explicit waypoint in Aviva's transformation is delivery against the £15–£20bn BPA volume target over 2022–24, which will test the scalability and capital efficiency of its retirement franchise. The interaction between that growth ambition, ongoing capital returns and the group's Solvency II own funds generation will frame the next phase of the strategy narrative.
